Search research articles
Contact Us
Filters
Showing results (151-160 of 187) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2018
An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations
Nicholas Pulliam, Fang Fang, Ali R Ozes, et al.
The New England Journal of Medicine
|
March 29, 2012
Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer
Jonathan Ledermann, Philipp Harter, Charlie Gourley, et al.
The Oncologist
|
June 14, 2025
First-in-human phase I/II, open-label study of mRNA-2416 alone or combined with durvalumab in patients with advanced solid tumors and ovarian cancer
Ryan J Sullivan, Oladapo O Yeku, Deanna Teoh, et al.
Geophysical Research Letters
|
July 28, 2020
Quantification of the Arctic Sea Ice-Driven Atmospheric Circulation Variability in Coordinated Large Ensemble Simulations
Yu-Chiao Liang, Young-Oh Kwon, Claude Frankignoul, et al.
Gynecologic Oncology
|
July 5, 2025
Fit4Surgery: A pilot randomized controlled trial to assess the feasibility of prehabilitation prior to debulking surgery for ovarian cancer
Jason N Silberman, Annella Benjamin, Payton Solk, et al.
Molecular Metabolism
|
April 23, 2026
Oleic Acid Fuels Cisplatin-Resistant Ovarian Cancer Through FABP4-Driven Lipid Uptake
Ana Maria Isac, Andres Valdivia, Didi Zha, et al.
Gynecologic Oncology
|
August 22, 2021
Efficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer, an NCCN phase II trial
Mathew Cowan, Wendy M Swetzig, Valery Adorno-Cruz, et al.
Journal of Personalized Medicine
|
September 28, 2023
HPLC Analysis and Risk Assessment of 15 Priority PAHs in Human Blood Serum of COPD Patient from Urban and Rural Areas, Iasi (Romania)
Ioana Buculei, Mona Elisabeta Dobrin, Daniela Matei, et al.
Cancer Research
|
November 11, 2020
Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis
Yinu Wang, Guangyuan Zhao, Salvatore Condello, et al.
NPJ Genomic Medicine
|
December 2, 2024
Comparative transcriptomic, epigenomic and immunological analyses identify drivers of disparity in high-grade serous ovarian cancer
Hao Huang, Russel Keathley, Ujin Kim, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 187) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2018
An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations
Nicholas Pulliam, Fang Fang, Ali R Ozes, et al.
The New England Journal of Medicine
|
March 29, 2012
Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer
Jonathan Ledermann, Philipp Harter, Charlie Gourley, et al.
The Oncologist
|
June 14, 2025
First-in-human phase I/II, open-label study of mRNA-2416 alone or combined with durvalumab in patients with advanced solid tumors and ovarian cancer
Ryan J Sullivan, Oladapo O Yeku, Deanna Teoh, et al.
Geophysical Research Letters
|
July 28, 2020
Quantification of the Arctic Sea Ice-Driven Atmospheric Circulation Variability in Coordinated Large Ensemble Simulations
Yu-Chiao Liang, Young-Oh Kwon, Claude Frankignoul, et al.
Gynecologic Oncology
|
July 5, 2025
Fit4Surgery: A pilot randomized controlled trial to assess the feasibility of prehabilitation prior to debulking surgery for ovarian cancer
Jason N Silberman, Annella Benjamin, Payton Solk, et al.
Molecular Metabolism
|
April 23, 2026
Oleic Acid Fuels Cisplatin-Resistant Ovarian Cancer Through FABP4-Driven Lipid Uptake
Ana Maria Isac, Andres Valdivia, Didi Zha, et al.
Gynecologic Oncology
|
August 22, 2021
Efficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer, an NCCN phase II trial
Mathew Cowan, Wendy M Swetzig, Valery Adorno-Cruz, et al.
Journal of Personalized Medicine
|
September 28, 2023
HPLC Analysis and Risk Assessment of 15 Priority PAHs in Human Blood Serum of COPD Patient from Urban and Rural Areas, Iasi (Romania)
Ioana Buculei, Mona Elisabeta Dobrin, Daniela Matei, et al.
Cancer Research
|
November 11, 2020
Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis
Yinu Wang, Guangyuan Zhao, Salvatore Condello, et al.
NPJ Genomic Medicine
|
December 2, 2024
Comparative transcriptomic, epigenomic and immunological analyses identify drivers of disparity in high-grade serous ovarian cancer
Hao Huang, Russel Keathley, Ujin Kim, et al.
Page
of 19